MeiraGTx (MGTX) Competitors $9.49 -0.09 (-0.94%) Closing price 04:00 PM EasternExtended Trading$9.98 +0.49 (+5.15%) As of 05:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MGTX vs. TLX, TWST, OGN, BEAM, and TNGXShould you buy MeiraGTx stock or one of its competitors? MarketBeat compares MeiraGTx with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with MeiraGTx include Telix Pharmaceuticals (TLX), Twist Bioscience (TWST), Organon & Co. (OGN), Beam Therapeutics (BEAM), and Tango Therapeutics (TNGX). These companies are all part of the "pharmaceutical products" industry. MGTX vs. TLXMGTX vs. TWSTMGTX vs. OGNMGTX vs. BEAMMGTX vs. TNGXHow does MeiraGTx compare to Telix Pharmaceuticals?MeiraGTx (NASDAQ:MGTX) and Telix Pharmaceuticals (NASDAQ:TLX) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, analyst recommendations, valuation, risk, dividends and institutional ownership. Which has more volatility & risk, MGTX or TLX? MeiraGTx has a beta of 1.23, meaning that its stock price is 23% more volatile than the broader market. Comparatively, Telix Pharmaceuticals has a beta of 0.08, meaning that its stock price is 92% less volatile than the broader market. Is MGTX or TLX more profitable? Telix Pharmaceuticals has a net margin of 0.00% compared to MeiraGTx's net margin of -151.12%. Telix Pharmaceuticals' return on equity of 0.00% beat MeiraGTx's return on equity.Company Net Margins Return on Equity Return on Assets MeiraGTx-151.12% -1,065.47% -54.96% Telix Pharmaceuticals N/A N/A N/A Which has preferable earnings and valuation, MGTX or TLX? Telix Pharmaceuticals has higher revenue and earnings than MeiraGTx. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMeiraGTx$81.39M10.80-$114.20M-$1.48N/ATelix Pharmaceuticals$803.79M4.34-$7.12MN/AN/A Does the media prefer MGTX or TLX? In the previous week, MeiraGTx had 4 more articles in the media than Telix Pharmaceuticals. MarketBeat recorded 8 mentions for MeiraGTx and 4 mentions for Telix Pharmaceuticals. MeiraGTx's average media sentiment score of 0.40 beat Telix Pharmaceuticals' score of -0.04 indicating that MeiraGTx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MeiraGTx 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Telix Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts recommend MGTX or TLX? MeiraGTx currently has a consensus target price of $25.83, indicating a potential upside of 172.22%. Telix Pharmaceuticals has a consensus target price of $21.13, indicating a potential upside of 105.70%. Given MeiraGTx's higher possible upside, equities analysts clearly believe MeiraGTx is more favorable than Telix Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MeiraGTx 1 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.75Telix Pharmaceuticals 1 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.78 Do institutionals & insiders have more ownership in MGTX or TLX? 67.5% of MeiraGTx shares are owned by institutional investors. 7.5% of MeiraGTx shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. SummaryMeiraGTx and Telix Pharmaceuticals tied by winning 7 of the 14 factors compared between the two stocks.How does MeiraGTx compare to Twist Bioscience?Twist Bioscience (NASDAQ:TWST) and MeiraGTx (NASDAQ:MGTX) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk, media sentiment and dividends. Which has more risk & volatility, TWST or MGTX? Twist Bioscience has a beta of 2.22, suggesting that its stock price is 122% more volatile than the broader market. Comparatively, MeiraGTx has a beta of 1.23, suggesting that its stock price is 23% more volatile than the broader market. Is TWST or MGTX more profitable? Twist Bioscience has a net margin of -19.85% compared to MeiraGTx's net margin of -151.12%. Twist Bioscience's return on equity of -26.73% beat MeiraGTx's return on equity.Company Net Margins Return on Equity Return on Assets Twist Bioscience-19.85% -26.73% -19.15% MeiraGTx -151.12%-1,065.47%-54.96% Do analysts prefer TWST or MGTX? Twist Bioscience currently has a consensus price target of $56.57, indicating a potential downside of 3.86%. MeiraGTx has a consensus price target of $25.83, indicating a potential upside of 172.22%. Given MeiraGTx's higher probable upside, analysts plainly believe MeiraGTx is more favorable than Twist Bioscience.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Twist Bioscience 1 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.75MeiraGTx 1 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.75 Which has better valuation & earnings, TWST or MGTX? Twist Bioscience has higher revenue and earnings than MeiraGTx. Twist Bioscience is trading at a lower price-to-earnings ratio than MeiraGTx, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTwist Bioscience$376.57M9.73-$77.67M-$1.33N/AMeiraGTx$81.39M10.80-$114.20M-$1.48N/A Do institutionals and insiders have more ownership in TWST or MGTX? 67.5% of MeiraGTx shares are held by institutional investors. 3.1% of Twist Bioscience shares are held by insiders. Comparatively, 7.5% of MeiraGTx shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the media favor TWST or MGTX? In the previous week, MeiraGTx had 3 more articles in the media than Twist Bioscience. MarketBeat recorded 8 mentions for MeiraGTx and 5 mentions for Twist Bioscience. MeiraGTx's average media sentiment score of 0.40 beat Twist Bioscience's score of 0.26 indicating that MeiraGTx is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Twist Bioscience 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral MeiraGTx 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryTwist Bioscience and MeiraGTx tied by winning 8 of the 16 factors compared between the two stocks.How does MeiraGTx compare to Organon & Co.?MeiraGTx (NASDAQ:MGTX) and Organon & Co. (NYSE:OGN) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends. Which has better earnings & valuation, MGTX or OGN? Organon & Co. has higher revenue and earnings than MeiraGTx. MeiraGTx is trading at a lower price-to-earnings ratio than Organon & Co., indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMeiraGTx$81.39M10.80-$114.20M-$1.48N/AOrganon & Co.$6.16B0.57$187M$0.9314.44 Which has more volatility and risk, MGTX or OGN? MeiraGTx has a beta of 1.23, meaning that its share price is 23% more volatile than the broader market. Comparatively, Organon & Co. has a beta of 1.57, meaning that its share price is 57% more volatile than the broader market. Do insiders and institutionals have more ownership in MGTX or OGN? 67.5% of MeiraGTx shares are held by institutional investors. Comparatively, 77.4% of Organon & Co. shares are held by institutional investors. 7.5% of MeiraGTx shares are held by company insiders. Comparatively, 1.6% of Organon & Co. shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the media favor MGTX or OGN? In the previous week, MeiraGTx and MeiraGTx both had 8 articles in the media. Organon & Co.'s average media sentiment score of 0.67 beat MeiraGTx's score of 0.40 indicating that Organon & Co. is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MeiraGTx 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Organon & Co. 3 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend MGTX or OGN? MeiraGTx currently has a consensus target price of $25.83, indicating a potential upside of 172.22%. Organon & Co. has a consensus target price of $11.40, indicating a potential downside of 15.08%. Given MeiraGTx's stronger consensus rating and higher probable upside, research analysts plainly believe MeiraGTx is more favorable than Organon & Co..Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MeiraGTx 1 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.75Organon & Co. 2 Sell rating(s) 5 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.71 Is MGTX or OGN more profitable? Organon & Co. has a net margin of 3.99% compared to MeiraGTx's net margin of -151.12%. Organon & Co.'s return on equity of 99.95% beat MeiraGTx's return on equity.Company Net Margins Return on Equity Return on Assets MeiraGTx-151.12% -1,065.47% -54.96% Organon & Co. 3.99%99.95%6.22% SummaryOrganon & Co. beats MeiraGTx on 10 of the 16 factors compared between the two stocks.How does MeiraGTx compare to Beam Therapeutics?MeiraGTx (NASDAQ:MGTX) and Beam Therapeutics (NASDAQ:BEAM) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, media sentiment, risk, valuation, institutional ownership, profitability, dividends and analyst recommendations. Do institutionals and insiders hold more shares of MGTX or BEAM? 67.5% of MeiraGTx shares are held by institutional investors. Comparatively, 99.7% of Beam Therapeutics shares are held by institutional investors. 7.5% of MeiraGTx shares are held by company insiders. Comparatively, 3.8% of Beam Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Is MGTX or BEAM more profitable? Beam Therapeutics has a net margin of -39.66% compared to MeiraGTx's net margin of -151.12%. Beam Therapeutics' return on equity of -29.00% beat MeiraGTx's return on equity.Company Net Margins Return on Equity Return on Assets MeiraGTx-151.12% -1,065.47% -54.96% Beam Therapeutics -39.66%-29.00%-22.61% Which has more risk & volatility, MGTX or BEAM? MeiraGTx has a beta of 1.23, indicating that its share price is 23% more volatile than the broader market. Comparatively, Beam Therapeutics has a beta of 2.26, indicating that its share price is 126% more volatile than the broader market. Does the media prefer MGTX or BEAM? In the previous week, Beam Therapeutics had 12 more articles in the media than MeiraGTx. MarketBeat recorded 20 mentions for Beam Therapeutics and 8 mentions for MeiraGTx. MeiraGTx's average media sentiment score of 0.40 beat Beam Therapeutics' score of -0.51 indicating that MeiraGTx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MeiraGTx 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Beam Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative Which has higher valuation & earnings, MGTX or BEAM? Beam Therapeutics has higher revenue and earnings than MeiraGTx. Beam Therapeutics is trading at a lower price-to-earnings ratio than MeiraGTx, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMeiraGTx$81.39M10.80-$114.20M-$1.48N/ABeam Therapeutics$139.74M20.37-$79.99M-$0.68N/A Do analysts rate MGTX or BEAM? MeiraGTx presently has a consensus price target of $25.83, suggesting a potential upside of 172.22%. Beam Therapeutics has a consensus price target of $46.83, suggesting a potential upside of 69.26%. Given MeiraGTx's stronger consensus rating and higher probable upside, research analysts plainly believe MeiraGTx is more favorable than Beam Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MeiraGTx 1 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.75Beam Therapeutics 1 Sell rating(s) 3 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 2.71 SummaryBeam Therapeutics beats MeiraGTx on 11 of the 16 factors compared between the two stocks.How does MeiraGTx compare to Tango Therapeutics?MeiraGTx (NASDAQ:MGTX) and Tango Therapeutics (NASDAQ:TNGX) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, earnings, dividends, institutional ownership, media sentiment, valuation, profitability and analyst recommendations. Is MGTX or TNGX more profitable? MeiraGTx has a net margin of -151.12% compared to Tango Therapeutics' net margin of -151.15%. Tango Therapeutics' return on equity of -41.54% beat MeiraGTx's return on equity.Company Net Margins Return on Equity Return on Assets MeiraGTx-151.12% -1,065.47% -54.96% Tango Therapeutics -151.15%-41.54%-33.44% Which has more volatility & risk, MGTX or TNGX? MeiraGTx has a beta of 1.23, indicating that its share price is 23% more volatile than the broader market. Comparatively, Tango Therapeutics has a beta of 1.22, indicating that its share price is 22% more volatile than the broader market. Do analysts rate MGTX or TNGX? MeiraGTx currently has a consensus price target of $25.83, suggesting a potential upside of 172.22%. Tango Therapeutics has a consensus price target of $32.27, suggesting a potential upside of 49.27%. Given MeiraGTx's stronger consensus rating and higher probable upside, analysts plainly believe MeiraGTx is more favorable than Tango Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MeiraGTx 1 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.75Tango Therapeutics 1 Sell rating(s) 3 Hold rating(s) 10 Buy rating(s) 0 Strong Buy rating(s) 2.64 Do insiders and institutionals hold more shares of MGTX or TNGX? 67.5% of MeiraGTx shares are held by institutional investors. Comparatively, 79.0% of Tango Therapeutics shares are held by institutional investors. 7.5% of MeiraGTx shares are held by insiders. Comparatively, 6.5% of Tango Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has preferable valuation and earnings, MGTX or TNGX? Tango Therapeutics has lower revenue, but higher earnings than MeiraGTx. Tango Therapeutics is trading at a lower price-to-earnings ratio than MeiraGTx, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMeiraGTx$81.39M10.80-$114.20M-$1.48N/ATango Therapeutics$62.38M50.13-$101.59M-$0.83N/A Does the media favor MGTX or TNGX? In the previous week, Tango Therapeutics had 1 more articles in the media than MeiraGTx. MarketBeat recorded 9 mentions for Tango Therapeutics and 8 mentions for MeiraGTx. MeiraGTx's average media sentiment score of 0.40 beat Tango Therapeutics' score of 0.38 indicating that MeiraGTx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MeiraGTx 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Tango Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryMeiraGTx beats Tango Therapeutics on 9 of the 17 factors compared between the two stocks. Get MeiraGTx News Delivered to You Automatically Sign up to receive the latest news and ratings for MGTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MGTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MGTX vs. The Competition ExportMetricMeiraGTxMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$878.87M$3.36B$6.34B$12.28BDividend YieldN/A2.32%2.80%5.36%P/E Ratio-6.4119.0220.9225.48Price / Sales10.80278.81521.1573.33Price / CashN/A125.3543.1855.00Price / Book-15.066.909.987.01Net Income-$114.20M$24.23M$3.55B$335.16M7 Day Performance-4.62%0.65%0.40%-0.30%1 Month Performance-6.69%-0.55%-0.04%1.14%1 Year Performance79.06%63.42%34.95%34.69% MeiraGTx Competitors List ExportCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MGTXMeiraGTx2.9685 of 5 stars$9.49-0.9%$25.83+172.2%+74.2%$878.87M$81.39MN/A300News CoverageEarnings ReportInsider TradeTLXTelix Pharmaceuticals4.4619 of 5 stars$10.83+1.4%$21.13+95.1%-37.3%$3.62B$803.79MN/A1,184TWSTTwist Bioscience1.5099 of 5 stars$56.21-1.1%$56.57+0.6%+73.6%$3.54B$376.57MN/A990Gap UpOGNOrganon & Co.2.8372 of 5 stars$13.33-0.2%$11.40-14.4%+54.1%$3.51B$6.16B14.3310,000BEAMBeam Therapeutics3.5052 of 5 stars$31.75-1.8%$47.17+48.6%+52.7%$3.33B$139.74MN/A510Analyst ForecastGap Down Related Companies and Tools Related Companies TLX Competitors TWST Competitors OGN Competitors BEAM Competitors TNGX Competitors ORKA Competitors RCUS Competitors ERAS Competitors DNLI Competitors ALMS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MGTX) was last updated on 5/21/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MeiraGTx Holdings PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share MeiraGTx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
